Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey


Kilickap S., Ozturk A., Karadurmus N., Korkmaz T., Yumuk P., Cicin I., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.13, no.10, 2018 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 13 Issue: 10
  • Publication Date: 2018
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: NSCLC, ALK inhibitor, crizotinib
  • Akdeniz University Affiliated: Yes